285
Views
32
CrossRef citations to date
0
Altmetric
Drug Evaluation

Fludarabine in chronic lymphocytic leukaemia

, &
Pages 1641-1651 | Published online: 28 Jul 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Maliha Khan, Jamie L Gibbons & Alessandra Ferrajoli. (2017) Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia. OncoTargets and Therapy 10, pages 1909-1914.
Read now
Anders Österborg. (2010) Ofatumumab, a human anti-CD20 monoclonal antibody. Expert Opinion on Biological Therapy 10:3, pages 439-449.
Read now
S. Henrich, S. Gez, B. Crossett, S.P. Mulligan & R.I. Christopherson. (2008) Fludarabine Induces Differential Expression of Proteins in Human Leukemia and Lymphoma Cells. Nucleosides, Nucleotides & Nucleic Acids 27:6-7, pages 634-640.
Read now

Articles from other publishers (29)

Noushin Lotfi, Zahra Yousefi, Marjan Golabi, Parvin Khalilian, Behrooz Ghezelbash, Mina Montazeri, Mohammad Hossein Shams, Parnian Zolfaghari Baghbadorani & Nahid Eskandari. (2023) The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update. Frontiers in Immunology 14.
Crossref
Saba Tariq, Sundus Tariq, Maliha Khan, Aysha Azhar & Mukhtiar Baig. (2020) Venetoclax in the Treatment of Chronic Lymphocytic Leukemia: Evidence, Expectations, and Future Prospects. Cureus.
Crossref
IntisarShakir Ali, GhassanAhmed Al-Ani, YaseenM Taher & AlaaFadhil Alwan. (2020) Prognostic values of β2 microglobulin, interleukin-4, and interleukin-6 in patients with different stages of chronic lymphocytic leukemia. Iraqi Journal of Hematology 9:1, pages 47.
Crossref
Amnon Peled, Shiri Klein, Katia Beider, Jan A. Burger & Michal Abraham. (2018) Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies. Cytokine 109, pages 11-16.
Crossref
Filipa Mousinho, Tatiana Mendes, Paula Sousa e Santos, Maria João Acosta, José Pereira, Maria Arroz, Cândido Silva, Ana Paula Azevedo, Rita Oliveira, Martinha Chorão & Fernando Lima. (2018) Treatment Sequencing in a Chronic Lymphocytic Leukemia Patient with Central Nervous System Involvement. Case Reports in Hematology 2018, pages 1-5.
Crossref
Leili Aghebati-Maleki, Mahdi Shabani, Behzad Baradaran, Morteza Motallebnezhad, Jafar Majidi & Mehdi Yousefi. (2017) Receptor tyrosine kinase-like orphan receptor 1 (ROR-1): An emerging target for diagnosis and therapy of chronic lymphocytic leukemia. Biomedicine & Pharmacotherapy 88, pages 814-822.
Crossref
L M Saleh, W Wang, S E M Herman, N S Saba, V Anastas, E Barber, M Corrigan-Cummins, M Farooqui, C Sun, S M Sarasua, Z Zhao, N K Abousamra, O Elbaz, H A Abdelghaffar, A Wiestner & K R Calvo. (2016) Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia. Leukemia 31:2, pages 340-349.
Crossref
Ju-Yoon Yoon, Ganchimeg Ishdorj, Bonnie A. Graham, James B. Johnston & Spencer B. Gibson. (2013) Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells. Apoptosis 19:1, pages 191-200.
Crossref
May Shawi, Tsz Wai Chu, Veronica Martinez-Marignac, Y. Yu, Sergei M. Gryaznov, James B. Johnston, Susan P. Lees-Miller, Sarit E. Assouline, Chantal Autexier & Raquel Aloyz. (2013) Telomerase Contributes to Fludarabine Resistance in Primary Human Leukemic Lymphocytes. PLoS ONE 8:7, pages e70428.
Crossref
Jan A. Burger & Emili Montserrat. (2013) Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling. Blood 121:9, pages 1501-1509.
Crossref
Mohammed Shanshal & Rami Y. Haddad. (2012) Chronic Lymphocytic Leukemia. Disease-a-Month 58:4, pages 153-167.
Crossref
G Ungerechts, M E Frenzke, K-C Yaiw, T Miest, P B Johnston & R Cattaneo. (2010) Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics. Gene Therapy 17:12, pages 1506-1516.
Crossref
Faith A.A. Kwa, Merrole Cole-Sinclair & Miroslav Kapuscinski. (2010) Chlorambucil-sensitive and -resistant lymphoid cells display different responses to the histone deacetylase inhibitor, sodium butyrate. Biochemical and Biophysical Research Communications 403:3-4, pages 288-292.
Crossref
Paula Fernández-Calotti & Marçal Pastor-Anglada. (2010) All-trans-retinoic Acid Promotes Trafficking of Human Concentrative Nucleoside Transporter-3 (hCNT3) to the Plasma Membrane by a TGF-β1-mediated Mechanism. Journal of Biological Chemistry 285:18, pages 13589-13598.
Crossref
Wei Yin, Elena V. Karyagina, Ante S. Lundberg, David J. Greenblatt & John Lister‐James. (2009) Pharmacokinetics, bioavailability and effects on electrocardiographic parameters of oral fludarabine phosphate. Biopharmaceutics & Drug Disposition 31:1, pages 72-81.
Crossref
J Bolaños-Meade, L Luznik, M Muth, W H Matsui, C A Huff, B D Smith, M Y Levy, Y L Kasamon, L J Swinnen, J D Powell, R A Brodsky, R F Ambinder, R J Jones & E J Fuchs. (2008) Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen. Bone Marrow Transplantation 43:6, pages 477-480.
Crossref
Sona Cejkova, Ludmila Rocnova, David Potesil, Jana Smardova, Vera Novakova, Jitka Chumchalova, Dita Zezulkova, Marek Borsky, Michael Doubek, Yvona Brychtova, Sarka Pospisilova, Martin Klabusay, Jiri Mayer & Martin Trbusek. (2009) Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine. European Journal of Haematology 82:2, pages 133-142.
Crossref
Dunyaporn Trachootham, Hui ZhangWan ZhangLi FengMin DuYan ZhouZhao ChenHelene PelicanoWilliam Plunkett, William G. Wierda, Michael J. Keating & Peng Huang. (2008) Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism. Blood 112:5, pages 1912-1922.
Crossref
Xiaobin Zhao, Jianmei Wu, Natarajan Muthusamy, John C. Byrd & Robert J. Lee. (2008) Liposomal Coencapsulated Fludarabine and Mitoxantrone for Lymphoproliferative Disorder Treatment**Xiaobin Zhao and Jianmei Wu contributed equally to this study.. Journal of Pharmaceutical Sciences 97:4, pages 1508-1518.
Crossref
Anathbandhu ChaudhuriBo YangHoward E. GendelmanYuri Persidsky & Georgette D. Kanmogne. (2008) STAT1 signaling modulates HIV-1–induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 111:4, pages 2062-2072.
Crossref
Paula Fernández Calotti, Carlos María Galmarini, Cristian Cañones, Romina Gamberale, Daniel Saénz, Julio Sánchez Avalos, Mónica Chianelli, Ruth Rosenstein & Mirta Giordano. (2008) Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia. Biochemical Pharmacology 75:4, pages 857-865.
Crossref
Sivasubramanian Baskar, Ka Yin Kwong, Thomas Hofer, Jessica M. Levy, Michael G. Kennedy, Elinor Lee, Louis M. Staudt, Wyndham H. Wilson, Adrian Wiestner & Christoph Rader. (2008) Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-Cell Chronic Lymphocytic Leukemia. Clinical Cancer Research 14:2, pages 396-404.
Crossref
Chor-Sang Chim, Florence Loong, Wai-Kuen Ng & Yok-Lam Kwong. (2008) Use of Fludarabine-Containing Chemotherapeutic Regimen Results in Durable Complete Remission of Subcutaneous Panniculitis-Like T-Cell Lymphoma. American Journal of Clinical Dermatology 9:6, pages 396-398.
Crossref
Jose Manuel Calvo-Villas, Basilio Martín Urcuyo, Adelaida Morales Umpierrez & Francisco Sicilia. (2008) Acute Tumor Lysis Syndrome during Oral Fludarabine Treatment for Chronic Lymphocytic Leukemia. Role of Treatment with Rasburicase. Onkologie 31:4, pages 197-199.
Crossref
Mollie Moran, Mary Browning & Emma Buckby. (2007) Nursing Guidelines for Managing Infections in Patients With Chronic Lymphocytic Leukemia. Clinical Journal of Oncology Nursing 11:6, pages 914-924.
Crossref
Ola Landgren & Robert A. Kyle. (2007) Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases. British Journal of Haematology 139:5, pages 717-723.
Crossref
Guy Ungerechts, Christoph Springfeld, Marie E. Frenzke, Johanna Lampe, Patrick B. Johnston, William B. Parker, Eric J. Sorscher & Roberto Cattaneo. (2007) Lymphoma Chemovirotherapy: CD20-Targeted and Convertase-Armed Measles Virus Can Synergize with Fludarabine. Cancer Research 67:22, pages 10939-10947.
Crossref
Christina L. Kress, Marina Konopleva, Vanesa Martínez-García, Maryla Krajewska, Sophie Lefebvre, Marc L. Hyer, Teresa McQueen, Michael Andreeff, John C. Reed & Juan M. Zapata. (2007) Triterpenoids Display Single Agent Anti-tumor Activity in a Transgenic Mouse Model of Chronic Lymphocytic Leukemia and Small B Cell Lymphoma. PLoS ONE 2:6, pages e559.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.